Anti-CD20 therapy for severe and refractory lupus nephritis (RLN).: An original preliminary study

被引：0
|
作者：
Abud-Mendoza, C
Irazoque, F
Andrade, L
Cuevas-Orta, E
Valdés, RV
Santillán, E
Navarro-Cano, G
Saldaña-Barnard, M
González-Amaro, R
Borjas, JA
Aranda, F
机构：
[1] Univ Autonoma San Luis Potosi, Cent Hosp, Unidad Reg Reumatol & Osteoporosis, San Luis Potosi, SLP, Mexico
[2] Univ Autonoma San Luis Potosi, Cent Hosp, Fac Med, San Luis Potosi, SLP, Mexico
[3] Hosp 20 Noviembre, ISSSTE, Mexico City, DF, Mexico
来源：
JOURNAL OF RHEUMATOLOGY | 2006年 / 33卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：427 / 428
页数：2
相关论文
共 50 条
  • [21] Childhood refractory autoimmune haemolytic anaemia: Is there a role for anti-CD20 therapy (rituximab)?
    Mc Mahon, C
    Babu, L
    Hodgson, A
    Hayat, A
    Connell, NO
    Smith, OP
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (02) : 480 - 482
  • [22] Anti-CD20 monoclonal antibody therapy in refractory immune thrombocytopenic purpura.
    Delgado, J
    Bustos, JG
    Jimenez-Yuste, V
    Garcia, B
    de Paz, R
    Gracia, J
    Villar, A
    Quintana, M
    Hernandez-Navarro, F
    BLOOD, 2001, 98 (11) : 59B - 59B
  • [23] Anti-CD20 or anti-IgE therapy for severe chronic autoimmune urticaria Reply
    Kaplan, Allen P.
    Joseph, Kusumam
    Maykut, Robert J.
    Zeldin, Robert K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : 511 - 511
  • [24] Anti-CD20 therapy for inducing and maintaining remission in refractory systemic lupus erythematosus [Anti-CD20-therapie zur remissionsinduktion und -erhaltung bei therapierefraktärem systemischen lupus erythematodes]
    Chehab G.
    Sander O.
    Fischer-Betz R.
    Schneider M.
    Zeitschrift für Rheumatologie, 2007, 66 (4) : 328 - 336
  • [25] Successful treatment of refractory immune thrombocytopenia with anti-CD20 antibody in a patient with systemic lupus erythematosus
    Lee, J-W
    Kim, H-A
    Sung, J-M
    Suh, C-H
    LUPUS, 2010, 19 (02) : 227 - 228
  • [26] Anti-CD20 monoclonal antibody (rituximab) for refractory autoimmune thrombocytopenia in a girl with systemic lupus erythematosus
    ten Cate, R
    Smiers, FJ
    Bredius, RGM
    Lankester, AC
    van Suijlekom-Smit, LWA
    Huizinga, TW
    Egeler, RM
    RHEUMATOLOGY, 2004, 43 (02) : 244 - 245
  • [27] Longterm clinical and immunological effects of Anti-CD20 treatment in patients with refractory systemic lupus erythematosus
    Lindholm, Catharina
    Boerjesson-Asp, Katharina
    Zendjanchi, Kiandokht
    Sundqvist, Anna-Carin
    Tarkowski, Andrej
    Bokarewa, Maria
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (05) : 826 - 833
  • [28] Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system
    Tokunaga, Mikiko
    Saito, Kazuyoshi
    Kawabata, Daisuke
    Imura, Yoshitaka
    Fujii, Takao
    Nakayamada, Shingo
    Tsujimura, Shizuyo
    Nawata, Masao
    Iwata, Shigeru
    Azuma, Taeko
    Mimori, Tsuneyo
    Tanaka, Yoshiya
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (04) : 470 - 475
  • [29] Anti-CD20 monoclonal antibodies in Systemic Lupus Erythematosus
    Shah, Kavina
    Cragg, Mark
    Leandro, Maria
    Reddy, Venkat
    BIOLOGICALS, 2021, 69 : 1 - 14
  • [30] Development of anti-CD20 therapy for multiple sclerosis
    Bartok, Beatrix
    Silverman, Gregg J. J.
    EXPERIMENTAL CELL RESEARCH, 2011, 317 (09) : 1312 - 1318
12345